First, both drugs are exempt from prospective Utilization Review (also known as Prior authorization) requirements, so
prescribers don t have to get approval before prescribing, and dispensers don t have to worry about getting paid.
Second,
neither drug is on the California workers comp drug fee schedule, so employers and taxpayers have to pay 83% of the “average wholesale price”. AWP is a number made up by the drugs manufacturers, and can be anything they want it to be. Over the last four years,
the average cost of fenoprofen calcium (FP) sextupled (is now 6 times higher); ketoprofen s costs jumped more than ten times.